Profil
Eric Victory is currently Director at Licensing Executives Society USA & Canada, Inc. and Vice President-Corporate Development at Aurinia Pharmaceuticals, Inc. since 2024.
Formerly, Mr. Victory was Vice President at AstraZeneca PLC from 2002 to 2020.
Education includes undergraduate studies at Stanford University and an MBA from Northwestern University.
Postes actifs de Eric Victory
| Sociétés | Poste | Début |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/11/2024 |
Licensing Executives Society USA & Canada, Inc.
Licensing Executives Society USA & Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Operates association for intellectual property, technology, and business development professionals | Directeur/Membre du Conseil | - |
Anciens postes connus de Eric Victory
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2020 |
Formation de Eric Victory
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Licensing Executives Society USA & Canada, Inc.
Licensing Executives Society USA & Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Operates association for intellectual property, technology, and business development professionals | Commercial Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
















